COVID Pill Shows No Benefit In Younger Adults

  • Dr. David Boulware in the Department of Medicine spoke to the Associated Press about a large study published showing Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults.
  •  “Paxlovid will remain important for people at the highest risk of severe COVID-19, such as seniors and those with compromised immune systems,” said Boulware. “But for the vast majority of Americans who are now eligible, this really doesn’t have a lot of benefits.”
Click to read full article Go back home

Sign Up for Our Newsletter

Join our list!

Sign up here to get our daily newsletter with the top trending headlines.